Sage Therapeutics, Inc.

GOLDMAN SACHS GROUP INC

Report date

6/30/2025

Quarter

2025 Q2

Filed

8/14/2025

Shares

519,107

Value ($000)

4,734

Weight

0.0%

2019 Q4 - 2025 Q2 (23 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q2	8/14/2025	4,734	0.0%	519,107	6/30/2025
2025 Q1	6/27/2025	3,483	0.0%	438,053	3/31/2025
2024 Q4	2/11/2025	2,944	0.0%	542,247	12/31/2024
2024 Q3	11/14/2024	5,562	0.0%	770,321	9/30/2024
2024 Q2	8/13/2024	8,162	0.0%	751,565	6/30/2024
2024 Q1	5/15/2024	9,806	0.0%	523,254	3/31/2024
2023 Q4	5/14/2024	10,326	0.0%	476,506	12/31/2023
2023 Q3	5/15/2024	6,444	0.0%	313,106	9/30/2023
2023 Q2	5/14/2024	24,073	0.0%	511,965	6/30/2023
2023 Q1	5/14/2024	39,700	0.0%	946,138	3/31/2023
2022 Q4	5/14/2024	36,085	0.0%	946,116	12/31/2022
2022 Q3	5/14/2024	43,527	0.0%	1,111,522	9/30/2022
2022 Q2	5/14/2024	35,733	0.0%	1,106,276	6/30/2022
2022 Q1	5/16/2022	10,376	0.0%	313,457	3/31/2022
2021 Q4	2/17/2022	18,928	0.0%	444,959	12/31/2021
2021 Q3	1/20/2022	20,936	0.0%	472,494	9/30/2021
2021 Q2	8/13/2021	28,831	0.0%	507,506	6/30/2021
2021 Q1	5/17/2021	34,200	0.0%	456,907	3/31/2021
2020 Q4	2/12/2021	56,643	0.0%	654,760	12/31/2020
2020 Q3	11/13/2020	32,591	0.0%	533,235	9/30/2020
2020 Q2	8/12/2020	33,795	0.0%	812,785	6/30/2020
2020 Q1	5/15/2020	21,413	0.0%	745,588	3/31/2020
2019 Q4	2/14/2020	36,094	0.0%	499,992	12/31/2019